AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Up 452.6% in January

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 423,300 shares, a growth of 452.6% from the December 31st total of 76,600 shares. Currently, 11.7% of the shares of the company are short sold. Based on an average daily volume of 425,500 shares, the short-interest ratio is currently 1.0 days.

AquaBounty Technologies Stock Performance

NASDAQ:AQB traded down $0.12 during mid-day trading on Tuesday, reaching $0.70. 227,344 shares of the company’s stock were exchanged, compared to its average volume of 348,821. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.98 and a current ratio of 3.02. AquaBounty Technologies has a one year low of $0.47 and a one year high of $2.79. The business’s fifty day simple moving average is $0.80 and its two-hundred day simple moving average is $1.08. The firm has a market capitalization of $2.70 million, a PE ratio of -0.04 and a beta of 1.17.

AquaBounty Technologies (NASDAQ:AQB) last announced its quarterly earnings results on Tuesday, November 5th. The company reported ($0.88) EPS for the quarter, meeting analysts’ consensus estimates of ($0.88). The company had revenue of $0.05 million during the quarter, compared to analysts’ expectations of $0.10 million. AquaBounty Technologies had a negative return on equity of 18.20% and a negative net margin of 5,842.69%. During the same period in the prior year, the company earned ($1.60) EPS.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in AquaBounty Technologies stock. Epiq Partners LLC raised its stake in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 423.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 89,000 shares of the company’s stock after purchasing an additional 72,000 shares during the period. Epiq Partners LLC owned approximately 2.30% of AquaBounty Technologies worth $56,000 as of its most recent SEC filing. Institutional investors own 8.92% of the company’s stock.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.